"Today's deal creates certainty in uncertain times, delivers stability and predictability," von der Leyen told reporters ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

European pharmaceutical stocks have swooned while the broader market has climbed higher. As a result, stocks in the sector are looking like a buying opportunity.

On 4 July 2025, the EC fined Alchem and its subsidiary EUR 489,000 for their role in a long-running cartel concerning the active ...

Meanwhile, President Trump continues to push reciprocal levies and reshoring efforts, while pharma prepares for escalating ...